EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,075 | +164.6% | 5,770 | +131.4% | 0.01% | +166.7% |
| Q2 2023 | $47,641 | – | 2,493 | +49760.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 5 | -100.0% | 0.00% | -100.0% |
| Q3 2021 | $912,000 | +542.3% | 43,164 | +507.9% | 0.07% | +346.7% |
| Q4 2020 | $142,000 | +32.7% | 7,100 | +61.7% | 0.02% | +25.0% |
| Q3 2020 | $107,000 | +189.2% | 4,390 | +174.4% | 0.01% | +140.0% |
| Q2 2020 | $37,000 | +3600.0% | 1,600 | +1516.2% | 0.01% | – |
| Q3 2019 | $1,000 | -99.2% | 99 | -98.4% | 0.00% | -100.0% |
| Q2 2019 | $130,000 | -26.6% | 6,100 | -18.3% | 0.01% | -23.5% |
| Q1 2019 | $177,000 | +20.4% | 7,466 | -0.5% | 0.02% | +21.4% |
| Q4 2018 | $147,000 | -19.2% | 7,500 | -11.8% | 0.01% | +16.7% |
| Q2 2018 | $182,000 | -66.2% | 8,500 | -65.0% | 0.01% | -73.9% |
| Q1 2018 | $538,000 | +12.3% | 24,307 | +22.7% | 0.05% | 0.0% |
| Q3 2017 | $479,000 | +193.9% | 19,805 | +161.9% | 0.05% | +170.6% |
| Q1 2017 | $163,000 | -56.9% | 7,562 | -70.2% | 0.02% | -59.5% |
| Q4 2016 | $378,000 | +114.8% | 25,369 | +83.8% | 0.04% | +110.0% |
| Q3 2016 | $176,000 | +77.8% | 13,806 | -22.4% | 0.02% | +17.6% |
| Q3 2015 | $99,000 | – | 17,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |